99 related articles for article (PubMed ID: 30201309)
1. A gain-of-function study of amelioration of pentylenetetrazole-induced seizures by endogenous prostaglandin D
Kaushik MK; Aritake K; Cherasse Y; Sharma R; Urade Y
Neurosci Lett; 2018 Nov; 686():140-144. PubMed ID: 30201309
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin D(2) is crucial for seizure suppression and postictal sleep.
Kaushik MK; Aritake K; Kamauchi S; Hayaishi O; Huang ZL; Lazarus M; Urade Y
Exp Neurol; 2014 Mar; 253():82-90. PubMed ID: 24333565
[TBL] [Abstract][Full Text] [Related]
3. Commentary on Kaushik et al.: Prostaglandin D2 is crucial for seizure suppression and postictal sleep. Novel evidence supporting a role for prostanoid receptors in seizure control.
Mello CF; Oliveira MS
Exp Neurol; 2014 Jul; 257():157-61. PubMed ID: 24814715
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of pentylenetetrazol-induced seizures in rats by prostaglandin D2.
Akarsu ES; Mamuk S; Comert A
Epilepsy Res; 1998 Mar; 30(1):63-8. PubMed ID: 9551845
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-Like Prostaglandin D Synthase but Not Hemopoietic Prostaglandin D Synthase Deletion Causes Hypertension and Accelerates Thrombogenesis in Mice.
Song WL; Ricciotti E; Liang X; Grosser T; Grant GR; FitzGerald GA
J Pharmacol Exp Ther; 2018 Dec; 367(3):425-432. PubMed ID: 30305427
[TBL] [Abstract][Full Text] [Related]
6. Reduced susceptibility to induced seizures in the Neuroligin-3(R451C) mouse model of autism.
Hill-Yardin EL; Argyropoulos A; Hosie S; Rind G; Anderson P; Hannan AJ; O'Brien TJ
Neurosci Lett; 2015 Mar; 589():57-61. PubMed ID: 25592157
[TBL] [Abstract][Full Text] [Related]
7. The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains.
Watanabe M; Miyai A; Danjo S; Nakamura Y; Itoh K
Exp Neurol; 2013 Sep; 247():645-52. PubMed ID: 23499834
[TBL] [Abstract][Full Text] [Related]
8. Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors.
Oliveira MS; Furian AF; Rambo LM; Ribeiro LR; Royes LF; Ferreira J; Calixto JB; Mello CF
Neuroscience; 2008 Apr; 152(4):1110-8. PubMed ID: 18329178
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase.
Itoh K; Watanabe M
Neuroscience; 2009 Mar; 159(2):735-43. PubMed ID: 19162139
[TBL] [Abstract][Full Text] [Related]
10. Pentylenetetrazol-kindling in mice overexpressing heat shock protein 70.
Ammon-Treiber S; Grecksch G; Angelidis C; Vezyraki P; Höllt V; Becker A
Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):115-21. PubMed ID: 17333130
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep.
Qu WM; Huang ZL; Xu XH; Aritake K; Eguchi N; Nambu F; Narumiya S; Urade Y; Hayaishi O
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17949-54. PubMed ID: 17093043
[TBL] [Abstract][Full Text] [Related]
12. [The antiepileptic role of 3α-androstanediol on the epileptic rats induced by pentylenetetrazole].
Zhang YH; Cao YX; Ma Y; Guo X; Wang X
Sheng Li Xue Bao; 2012 Dec; 64(6):633-8. PubMed ID: 23258325
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and genotoxic evaluation of rosmarinic and caffeic acid in acute seizure models induced by pentylenetetrazole and pilocarpine in mice.
Coelho VR; Vieira CG; de Souza LP; da Silva LL; Pflüger P; Regner GG; Papke DK; Picada JN; Pereira P
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1195-1203. PubMed ID: 27476160
[TBL] [Abstract][Full Text] [Related]
14. Complete brain-type creatine kinase deficiency in mice blocks seizure activity and affects intracellular calcium kinetics.
Streijger F; Scheenen WJ; van Luijtelaar G; Oerlemans F; Wieringa B; Van der Zee CE
Epilepsia; 2010 Jan; 51(1):79-88. PubMed ID: 19624717
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant activity of an active fraction extracted from Crinum jagus L. (Amaryllidaceae), and its possible effects on fully kindled seizures, depression-like behaviour and oxidative stress in experimental rodent models.
Taiwe GS; Tchoya TB; Menanga JR; Dabole B; De Waard M
J Ethnopharmacol; 2016 Dec; 194():421-433. PubMed ID: 27725241
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Na+/Ca2+ exchanger in pentylenetetrazol-induced convulsion by use of Na+/Ca2+ exchanger knockout mice.
Saito R; Kaneko E; Tanaka Y; Honda K; Matsuda T; Baba A; Komuro I; Kita S; Iwamoto T; Takano Y
Biol Pharm Bull; 2009 Nov; 32(11):1928-30. PubMed ID: 19881311
[TBL] [Abstract][Full Text] [Related]
17. Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo.
Fujitani Y; Aritake K; Kanaoka Y; Goto T; Takahashi N; Fujimori K; Kawada T
FEBS J; 2010 Mar; 277(6):1410-9. PubMed ID: 20136655
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin D2 inhibits pentylenetetrazole-induced convulsions in rats by a serotonin-mediated mechanism.
Bhattacharya SK; Parmar SS
Pharm Res; 1987 Oct; 4(5):406-8. PubMed ID: 2977646
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury.
Taniguchi H; Mohri I; Okabe-Arahori H; Aritake K; Wada K; Kanekiyo T; Narumiya S; Nakayama M; Ozono K; Urade Y; Taniike M
J Neurosci; 2007 Apr; 27(16):4303-12. PubMed ID: 17442814
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic prostaglandin D synthase-derived prostaglandin D
Tsubosaka Y; Maehara T; Imai D; Nakamura T; Kobayashi K; Nagata N; Fujii W; Murata T
FASEB J; 2019 Jun; 33(6):6829-6837. PubMed ID: 30811953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]